Multi-directional Impact Protection System
Multi-directional Impact Protection System
| Type | Helmet safety technology |
|---|---|
| Inventor | |
| Inception | |
| Manufacturer | |
| Available | |
| Discontinued | |
| Website | [ Official website] |
| Related articles |
{{This technology related article is a stub.}}
The Multi-directional Impact Protection System (MIPS) is a technology used in helmets to improve safety by reducing rotational forces that can result from certain impacts. MIPS is designed to protect the brain from injuries that can occur during angled impacts to the head.
Overview[edit | edit source]
MIPS technology is based on the principle of mimicking the brain's own protection system. The human brain is surrounded by a low-friction layer that allows it to slide slightly within the skull during an impact. MIPS aims to replicate this mechanism by incorporating a low-friction layer inside the helmet, which allows the head to move 10-15 mm relative to the helmet in all directions, reducing the rotational motion transferred to the brain.
History[edit | edit source]
The concept of MIPS was developed in the 1990s by Swedish researchers Hans von Holst, a neurosurgeon, and Peter Halldin, a researcher at the Royal Institute of Technology in Stockholm. The first MIPS-equipped helmets were introduced to the market in the early 2000s.
Applications[edit | edit source]
MIPS technology is used in a variety of helmets, including those for cycling, motorcycling, skiing, and equestrian sports. It is also being integrated into helmets for team sports such as American football and hockey.
Benefits[edit | edit source]
The primary benefit of MIPS is the reduction of rotational forces on the brain during an impact. Studies have shown that helmets equipped with MIPS can significantly reduce the risk of concussion and other brain injuries compared to non-MIPS helmets.
Criticism[edit | edit source]
Some critics argue that the benefits of MIPS are overstated and that more independent research is needed to fully understand its effectiveness. However, many helmet manufacturers and safety organizations endorse MIPS as an important advancement in helmet safety technology.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
- [Official MIPS website](https://www.mipsprotection.com)
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
